We are live on
!
Find out more
KCA
KVP Capital Advisors Portfolio holdings
AUM
$136M
This Fund
S&P 500
This Quarter
Est. Return
+167.4%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$103M
AUM Growth
–
Cap. Flow
+$78.5M
Cap. Flow
% of AUM
76.01%
Top 10 Holdings %
Top 10 Hldgs %
68.49%
Holding
27
New
27
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TERN
Terns Pharmaceuticals
TERN
|
+$10.2M |
| 2 |
Praxis Precision Medicines
PRAX
|
+$7.99M |
| 3 |
Insmed
INSM
|
+$5.2M |
| 4 |
Axsome Therapeutics
AXSM
|
+$5.05M |
| 5 |
WHWK
Whitehawk Therapeutics
WHWK
|
+$4.97M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 93.69% |
| 2 | Miscellaneous | 6.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Celcuity
CELC
$4.33B
| $399K | 0.39% |
+4,000
| New | +$329K |
|
|
YARW
27
Yarrow Bioscience
YARW
$98.8M
| $290K | 0.28% |
+10,011
| New | +$201K |
|
Similar funds
RC
TH
WFA
SB
II
FEM
SCM
VSCP
KVP Capital Advisors's Q4 2025 Portfolio in Review
Q4 2025 is the first quarter with a 13F filing on record for KVP Capital Advisors, which disclosed 27 positions worth $103M. Its ten largest holdings account for 68% of the portfolio.
Its largest position is Terns Pharmaceuticals: 440,000 shares worth $17.8M.
By sector, the portfolio is most concentrated in Healthcare at 94% of assets, followed by Miscellaneous.
- KVP Capital Advisors's largest Q4 2025 buy was Terns Pharmaceuticals: 440,000 shares worth $17.8M.
- KVP Capital Advisors's ten largest holdings make up 68% of its $103M portfolio in Q4 2025.
- KVP Capital Advisors disclosed 27 positions in Q4 2025, its first 13F filing on record.
Based on KVP Capital Advisors's 13F filing for Q4 2025, filed 18 Feb 2026.